High-grade (Grades II and III) HNSCC presented intense AGR2 immunoreactivity compared with low-grade (Grade I, n=20) HNSCC (P < 0.001, Fig. 2A with quantities in Fig. 2B). Here, AGR2 is linked to head and neck squamous cell carcinoma.